|
|
Article: BD Announces Plan to Exit Blood Glucose Monitoring Market.
- Article from:
- PR Newswire
- Article date:
- September 28, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Conference Call With Analysts and Investors Scheduled for 11:00 a.m. (ET)
FRANKLIN LAKES, N.J., Sept. 28 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) announced today that it will exit the blood glucose monitoring (BGM) market. This action impacts BD's blood glucose monitors and test strips only. BD's other diabetes products, including insulin syringes, pen needles and lancets, will not be affected.
"We evaluate all of our businesses on an ongoing basis, and this decision was made after careful consideration of our prospects and our ability to create and deliver value in this market," stated Edward J. Ludwig, Chairman, President and ...